FDA Inspection 1326668 — Ingenus Pharmaceuticals NJ, LLC.
The FDA completed an inspection of Ingenus Pharmaceuticals NJ, LLC. on Jul 17, 2026 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 17, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Fairfield, NJ (United States)